Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03ETT
|
||||
Former ID |
DNC004027
|
||||
Drug Name |
Z-Ala-Leu-His-Agly-Ile-Val-OMe
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526417] | ||
Structure |
Download2D MOL |
||||
Formula |
C36H55N9O9
|
||||
Canonical SMILES |
CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CN=CN1<br />)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2
|
||||
InChI |
1S/C36H55N9O9/c1-9-22(6)29(33(49)42-28(21(4)5)34(50)53-8)43-35(51)45-44-32(48)27(16-25-17-37-19-38-25)41-31(47)26(15-20(2)3)40-30(46)23(7)39-36(52)54-18-24-13-11-10-12-14-24/h10-14,17,19-23,26-29H,9,15-16,18H2,1-8H3,(H,37,38)(H,39,52)(H,40,46)(H,41,47)(H,42,49)(H,44,48)(H2,43,45,51)
|
||||
InChIKey |
IVHANADPEKMLMO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin B | Target Info | Inhibitor | [526417] | |
Cathepsin K | Target Info | Inhibitor | [526417] | ||
Reactome | Collagen degradation | ||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
MHC class II antigen presentation | |||||
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.